NTES NTES
Company Profile ↓Company Overview
NTES (NTES) is a publicly traded company listed on with a market capitalization of $412.46B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 21.1%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 21.2%.
Net profit has compounded at 18.4% per year over the last five years.
Trades at an undemanding P/E of 2.4.
Maintains a net profit margin of 30.0%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $112.63B (+7.0% YoY); net profit $33.76B.
- Trailing 12 Months Year-on-year growth — revenue +7.0%, earnings +13.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 5.3%, profit CAGR 18.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 5.29% |
| 1 Year: | 6.96% |
Compounded Profit Growth
| 5 Years: | 18.40% |
| 1 Year: | 13.68% |
Stock Price Performance
| 1 Year: | +0.74% |
| 6 Months: | +1.40% |
| 3 Months: | +11.96% |
| 1 Month: | -2.07% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross1d ago
- RSI (14)50.70 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 21.1%.
- Healthy ROCE of 21.2%.
- Excellent profit margin of 30.0%.
- Profit CAGR of 18.4% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 28.83B | 27.89B | 28.36B | 27.55B | 30.59B |
| Cost of Revenue | 10.35B | 9.84B | 10.18B | 9.85B | 9.37B |
| Gross Profit | 18.48B | 18.05B | 18.18B | 17.69B | 21.22B |
| Operating Expenses | 8.04B | 8.99B | 10.16B | 9.37B | 8.56B |
| Operating Income | 10.44B | 9.06B | 8.01B | 8.32B | 12.66B |
| EBITDA | 10.92B | 9.49B | 8.63B | 9.04B | 13.09B |
| Interest Expense | - | - | - | - | - |
| Pretax Income | 12.45B | 10.65B | 10.11B | 7.62B | 13.37B |
| Tax Provision | 1.91B | 1.56B | 1.32B | 1.25B | 2.52B |
| Net Income | 10.30B | 8.60B | 8.62B | 6.24B | 10.67B |
| Diluted EPS | 16.05 | 13.35 | 13.35 | 9.65 | 16.55 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 96.50B | 103.47B | 105.30B | 112.63B |
| Cost of Revenue | - | 43.73B | 40.40B | 39.49B | 40.22B |
| Gross Profit | - | 52.77B | 63.06B | 65.81B | 72.40B |
| Operating Expenses | - | 33.14B | 35.35B | 36.22B | 36.57B |
| Operating Income | - | 19.63B | 27.71B | 29.58B | 35.83B |
| EBITDA | - | 22.49B | 30.76B | 32.00B | 38.08B |
| Interest Expense | - | - | - | - | - |
| Pretax Income | - | 24.25B | 34.06B | 35.72B | 40.83B |
| Tax Provision | - | 5.03B | 4.70B | 5.46B | 6.03B |
| Net Income | - | 20.34B | 29.42B | 29.70B | 33.76B |
| Diluted EPS | - | 30.85 | 45.25 | 45.95 | 52.40 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 172.76B | 185.92B | 195.99B | 221.42B |
| Current Assets | - | 131.60B | 142.69B | 153.32B | 180.62B |
| Cash & Equivalents | - | 24.89B | 21.43B | 51.38B | 47.17B |
| Inventory | - | 993.64M | 695.37M | 571.55M | 689.18M |
| Receivables | - | 5.00B | 6.42B | 5.67B | 5.34B |
| Total Liabilities | - | 63.89B | 57.84B | 53.50B | 56.31B |
| Current Liabilities | - | 56.83B | 53.84B | 49.67B | 52.37B |
| Long Term Debt | 1.28B | 3.65B | 428.00M | 428.00M | - |
| Total Debt | - | 28.46B | 20.48B | 12.82B | 6.73B |
| Total Equity | - | 104.73B | 124.29B | 138.69B | 160.30B |
| Shares Outstanding | - | 3.32B | 3.32B | 3.21B | 3.22B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 27.71B | 35.33B | 39.68B | 50.74B |
| Investing Cash Flow | - | -7.37B | -17.04B | 17.92B | -33.18B |
| Financing Cash Flow | - | -10.24B | -21.47B | -27.34B | -20.16B |
| Capital Expenditure | - | -2.64B | -4.28B | -2.21B | -2.05B |
| Free Cash Flow | - | 25.07B | 31.06B | 37.47B | 48.69B |
| Net Change in Cash | - | 10.10B | -3.18B | 30.26B | -2.60B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 54.7% | 60.9% | 62.5% | 64.3% |
| Operating Margin % | - | 20.3% | 26.8% | 28.1% | 31.8% |
| Net Margin % | - | 21.1% | 28.4% | 28.2% | 30.0% |
| ROE % | - | 19.4% | 23.7% | 21.4% | 21.1% |
| ROCE % | - | 16.9% | 21.0% | 20.2% | 21.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NTES
NTES or TYL: Which Is the Better Value Stock Right Now? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOMWN0YUh3SWFZRVZRZ05vcEVickV4Tk1JTzJxbmFBMXlwd3NjeEVCenVVWmpwUEdKWFVzLXlvcjFYVTFFemRjVDRLc1M3WnlVYl80RHk0V1F4WTZUc1BGZHVuWHdrbUN4Tm5LSG9kd0VLQWpmRGE2V3JGSGlFZ1BoVFFSUWZHY2YtMVRWT2…
Amundi Sells 7,643 Shares of NetEase, Inc. $NTES - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbFJQbVhlWGlRcTJHamRkbXhhREdBVXdySTZkcVpPRVdXcGxGNXE4OUlnRVV3VHpkNGk5V0tLb3o3MXRKWkRaSDNPRnNEZTB2RGc0MGFBa0dvN2ZmVHgwNFlSdlBTamkwbWdOakFHODYtWDkteXV4V3NJc1p2eGRQSmVJZVY2ODFuTEI3al…
NetEase (NASDAQ:NTES) Stock Dips 3.9% as Q1 Earnings Beat Fails to Offset Inline Revenue - ChartMill
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQYjJVbEZQTThXRndBZF9KX1hVYUhlSU5TdkI0OXczOVlxUllHUHUxVlNiNXFtanJtODN3T3FheWdDaGRvcUV1WnNsSHhuSEUyaklpRUx5ZnhWVGx5bW1mWUt4OHNLV0pLVUlPQTlMRm9kc3N2SHJhRmdLS1ZzVS1sUlhLeHBha2o3SXI5b1…
Fund Update: 7,212 NETEASE (NTES) shares added to Guinness Asset Management LTD portfolio - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxPclV3RWpzb1JnSmZGMnp6Q0F1T1NuSXZ4YmNnbENHT0JwVnh5emstLTlkMHVEMTV6S3lqa25TdWpNbldKTW9DM1BGM281ZlZzb014b2E5N1lmU1RtR2lpdTJQYnphX1A5VzhHbzEycklvdGZ6VGczbEhKTzVuLVhEZDJfUjBuQVFrSkNoNk…
Fund Update: 7,212 NETEASE (NTES) Shares Added to Guinness Asset Management LTD Portfolio - Moomoo
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPaE96dWQ2UmtCYTVseHQtbG5LeDVmZ1ZIdzVXb05HNlBIbkJiYVQyd2l3bm56cUxYQ3lwbjlLUnR6WDBvZ3R4N0NGSjVndnhNaFdodHBUcWoxU09tbTh0d2JzdWVoem8zbDdldnpEUHhqTWpNZWVnaE1QQ3RQM1h5cXo1RFotOFhlM29mZl…
Technical Reactions to NTES Trends in Macro Strategies - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNOEhoTHZSYzA4Q2ZLRnFVUm5LT2tJc1JIZU1TTXd3cEh0VnZuSEhIcDZtWC04V2JhaEJFd2dHSVN2MG44bVcxNklqaXNjOWo0dWg4d012a1hpTndGWnBMeXNnZnBqVF9pQ21lTHZZa1lpOFZvT1didi1ILXBQOEhrUmJXSkhJYm94SnBzc3…
NTES — Frequently Asked Questions
What is the current share price of NTES?
As of 2026-08-05 17:25 PDT, NTES trades at $128.11 on NASDAQ/NYSE. Its 52-week range is $108.62 to $156.20.
What is the market capitalisation of NTES?
NTES has a market capitalisation of $412.46B on NASDAQ/NYSE.
What is the P/E ratio of NTES?
NTES trades at a trailing price-to-earnings (P/E) ratio of 2.44. Its price-to-book (P/B) ratio is 2.57.
What is the return on equity (ROE) of NTES?
NTES has a return on equity (ROE) of 21.06%. Its return on capital employed (ROCE) is 21.20%.
Is NTES a good stock to buy?
This page provides a data-driven analysis of NTES, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.